IBDEI1TS ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32164,1,3,0)
 ;;=3^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,32164,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,32164,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,32165,0)
 ;;=L60.0^^182^1981^162
 ;;^UTILITY(U,$J,358.3,32165,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32165,1,3,0)
 ;;=3^Ingrowing Nail
 ;;^UTILITY(U,$J,358.3,32165,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,32165,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,32166,0)
 ;;=L60.1^^182^1981^235
 ;;^UTILITY(U,$J,358.3,32166,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32166,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,32166,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,32166,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,32167,0)
 ;;=L60.2^^182^1981^234
 ;;^UTILITY(U,$J,358.3,32167,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32167,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,32167,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,32167,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,32168,0)
 ;;=L60.3^^182^1981^171
 ;;^UTILITY(U,$J,358.3,32168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32168,1,3,0)
 ;;=3^Nail Dystrophy
 ;;^UTILITY(U,$J,358.3,32168,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,32168,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,32169,0)
 ;;=L60.4^^182^1981^88
 ;;^UTILITY(U,$J,358.3,32169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32169,1,3,0)
 ;;=3^Beau's Lines
 ;;^UTILITY(U,$J,358.3,32169,1,4,0)
 ;;=4^L60.4
 ;;^UTILITY(U,$J,358.3,32169,2)
 ;;=^5009237
 ;;^UTILITY(U,$J,358.3,32170,0)
 ;;=L60.5^^182^1981^291
 ;;^UTILITY(U,$J,358.3,32170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32170,1,3,0)
 ;;=3^Yellow Nail Syndrome
 ;;^UTILITY(U,$J,358.3,32170,1,4,0)
 ;;=4^L60.5
 ;;^UTILITY(U,$J,358.3,32170,2)
 ;;=^5009238
 ;;^UTILITY(U,$J,358.3,32171,0)
 ;;=L60.8^^182^1981^169
 ;;^UTILITY(U,$J,358.3,32171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32171,1,3,0)
 ;;=3^Nail Disorders NEC
 ;;^UTILITY(U,$J,358.3,32171,1,4,0)
 ;;=4^L60.8
 ;;^UTILITY(U,$J,358.3,32171,2)
 ;;=^5009239
 ;;^UTILITY(U,$J,358.3,32172,0)
 ;;=L62.^^182^1981^170
 ;;^UTILITY(U,$J,358.3,32172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32172,1,3,0)
 ;;=3^Nail Disorders in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,32172,1,4,0)
 ;;=4^L62.
 ;;^UTILITY(U,$J,358.3,32172,2)
 ;;=^5009241
 ;;^UTILITY(U,$J,358.3,32173,0)
 ;;=L64.9^^182^1981^33
 ;;^UTILITY(U,$J,358.3,32173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32173,1,3,0)
 ;;=3^Androgenic Alopecia,Unspec
 ;;^UTILITY(U,$J,358.3,32173,1,4,0)
 ;;=4^L64.9
 ;;^UTILITY(U,$J,358.3,32173,2)
 ;;=^5009249
 ;;^UTILITY(U,$J,358.3,32174,0)
 ;;=L65.9^^182^1981^232
 ;;^UTILITY(U,$J,358.3,32174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32174,1,3,0)
 ;;=3^Nonscarring Hair Loss,Unspec
 ;;^UTILITY(U,$J,358.3,32174,1,4,0)
 ;;=4^L65.9
 ;;^UTILITY(U,$J,358.3,32174,2)
 ;;=^5009252
 ;;^UTILITY(U,$J,358.3,32175,0)
 ;;=L70.0^^182^1981^6
 ;;^UTILITY(U,$J,358.3,32175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32175,1,3,0)
 ;;=3^Acne Vulgaris
 ;;^UTILITY(U,$J,358.3,32175,1,4,0)
 ;;=4^L70.0
 ;;^UTILITY(U,$J,358.3,32175,2)
 ;;=^5009268
 ;;^UTILITY(U,$J,358.3,32176,0)
 ;;=L70.1^^182^1981^1
 ;;^UTILITY(U,$J,358.3,32176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32176,1,3,0)
 ;;=3^Acne Conglobata
 ;;^UTILITY(U,$J,358.3,32176,1,4,0)
 ;;=4^L70.1
 ;;^UTILITY(U,$J,358.3,32176,2)
 ;;=^5009269
 ;;^UTILITY(U,$J,358.3,32177,0)
 ;;=L70.3^^182^1981^5
 ;;^UTILITY(U,$J,358.3,32177,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32177,1,3,0)
 ;;=3^Acne Tropica
 ;;^UTILITY(U,$J,358.3,32177,1,4,0)
 ;;=4^L70.3
 ;;^UTILITY(U,$J,358.3,32177,2)
 ;;=^5009270
 ;;^UTILITY(U,$J,358.3,32178,0)
 ;;=L70.4^^182^1981^160
 ;;
 ;;$END ROU IBDEI1TS
